Utama › Penyakit Graft-versus-host › Florida

Kajian klinikal Penyakit Graft-versus-host di Florida

7 kajian untuk Penyakit Graft-versus-host sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

University of Miami, Miami

Mengambil pesertaFasa 1/2

Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05531786

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

University of Miami Sylvester Comprehensive Cancer Center, Miami

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06910969

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Moffitt Cancer Center, Tampa

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06450925

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Moffitt Cancer Center, Tampa

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

University of Miami, Miami

Mengambil pesertaFasa 2

Umur 2 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT04710576

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

University of Miami, Miami
Moffitt Cancer Center, Tampa

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06615050

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

AdventHealth Orlando, Orlando
Moffitt Cancer Center, Tampa

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.